NovoCure Ltd (NVCR): Cost of Revenue
$166.88M
Year ended 2025-12-31
$166.92M
Trailing 12 months to 2026-06-30
+13.3%
3-year compound annual growth
+9.4%
5-year compound annual growth
+23.3%
10-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $166.88M | +21.6% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $137.18M | +6.9% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $128.28M | +11.7% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $114.87M | 0.0% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $114.88M | +7.9% | 2024-02-22, From 2021-01-01 |
| 2020-12-31 | $106.50M | +20.2% | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | $88.61M | +10.7% | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | $80.05M | +43.9% | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $55.61M | +39.5% | 2020-02-27, From 2017-01-01 |
| 2016-12-31 | $39.87M | +93.4% | 2019-02-28, From 2016-01-01 |
| 2015-12-31 | $20.61M | +105.4% | 2018-02-22, From 2015-01-01 |
| 2014-12-31 | $10.04M | +43.1% | 2017-02-23, From 2014-01-01 |
| 2013-12-31 | $7.01M | n/a | 2016-03-01, From 2013-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| NovoCure Ltd (NVCR) | 2025-12-31 | $166.88M | +21.6% |
| UFP Technologies Inc (UFPT) | 2025-12-31 | $432.39M | +20.9% |
| iRhythm Holdings, Inc. (IRTC) | 2025-12-31 | $219.89M | +19.3% |
| Bioventus Inc. (BVS) | 2025-12-31 | $179.93M | -2.8% |
| Alphatec Holdings, Inc. (ATEC) | 2025-12-31 | $232.27M | +24.0% |
| AtriCure, Inc. (ATRC) | 2025-12-31 | $133.75M | +13.6% |
| Orthofix Medical Inc. (OFIX) | 2025-12-31 | $256.30M | +1.1% |
| Glaukos Corp (GKOS) | 2025-12-31 | $111.81M | +18.9% |
| Inspire Medical Systems, Inc. (INSP) | 2025-12-31 | $133.22M | +8.3% |
Compare NVCR, UFPT, IRTC, BVS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗